Specific sputum markers, including higher sputum eosinophils, macrophages, and lymphocyte counts, were associated with remission after interleukin-5 (IL-5)–targeted therapy for patients with severe ...

Eosinophil White Blood Cell What is the difference in efficacy between mepolizumab and benralizumab, 2 biologics approved for the treatment of severe eosinophilic asthma? Mepolizumab and benralizumab ...

Please provide your email address to receive an email when new articles are posted on . Benralizumab reduced levels of IgE circulating in the blood among patients with severe eosinophilic asthma but ...

March 9, 2009 — The anti-interleukin-5 monoclonal antibody mepolizumab may be helpful in refractory eosinophilic asthma, according to the results of 2 studies reported in the March 5 issue of the New ...

Eosinophilic asthma (e-asthma) is a rare form of the breathing disease that can be very hard to treat successfully. That can put you in a frustrating cycle of asthma attacks. People with e-asthma are ...

GlaxoSmithKline, caught up in an ever-increasingly competitive IL-5 respiratory market, has served up a new survey showing the frustrations of asthma patients. GSK, which markets Nucala for severe ...

Active eosinophilic esophagitis appears to be associated with lower lung function and increased asthma severity in children with comorbid asthma. Active eosinophilic esophagitis (EoE) appears to be ...

Please provide your email address to receive an email when new articles are posted on . Twelve months prior to benralizumab treatment, 380 patients received at least one biologic. Patients without vs.